Informazioni su di me

Formazione

• Master Universitario II livello in Andrologia e Medicina della Sessualità, 2013-2025, Università degli Studi di Firenze
• Dottorato di Ricerca in Biotecnologie Endocrinologiche, Molecolari e Rigenerative XXV Ciclo, 2009-2013, Università degli Studi di Firenze
• Specializzazione in Endocrinologia e Malattie del Metabolismo, 2009, Facoltà di Medicina e Chirurgia, Università degli Studi di Firenze con votazione 70/70 e lode
• Fellow of the European Committee of Sexual Medicine (FECSM), 2007-2008, accreditato dalla European Academy of Sexual Medicine
• Consulente in Sessuologia II Livello, 2006-2008, Istituto Internazionale di Sessuologia (IRF)
• Laurea in Medicina e Chirurgia, 2004, Università degli Studi di Firenze con votazione 110/110 e lode

Competenze linguistiche

• Italiano
• Inglese

Certificati

Premi e riconoscimenti

• Vincitrice del Best Journal Clinical Endocrinology and Metabolism 2016 (Fisher et al., J Clin Endocrinol Metab. 2016;101(11):4260-4269)

Pubblicazioni

• 111) A European Network for the Investigation of Gender Incongruence in adolescents. Boogers LS, Wiepjes CM, Staphorsius AS, Klink DT, Ciancia S, Romani A, Stolk T, van de Boogaard E, Steensma TD, de Vries ALC, van Trotsenburg ASP, den Heijer M, Fisher AD, Cools M, Hannema SE.J Sex Med. 2024 Mar 28;21(4):350-356
• 112) Dietary habits, physical activity and body mass index in transgender and gender diverse adults in Italy: a voluntary sampling observational study, Santangelo C, Marconi M, Ruocco A, Ristori J, Bonadonna S, Pivonello R, Meriggiola MC, Lombardo F, Motta G, Crespi CM, Mosconi M, Oppo A, Federici S, Bruno L, Verde N, Lami A, Bologna E, Varì R, Pagano MT, Giordani L, Matarrese P, Chiarotti F, Fisher AD and Pierdominici M, Jul 2024 Nutrients -3148133
• 110) Estimate and needs of the transgender adult population: the SPoT study. Fisher et al. J End Invest 2024
• 109) Back to the Future: Is GnRHa treatment in transgender and gender diverse adolescents only an extended evaluation phase? Fisher AD and Ristori J et al., JCEM 2023
• 108) Sociodemographic profile, health-related behaviours and experiences of healthcare access in Italian transgender and gender diverse adult population. Marconi M, Pagano MT, Ristori J, Bonadonna S, Pivonello R, Meriggiola MC, Motta G, Lombardo F, Mosconi M, Oppo A, Cocchetti C, Romani A, Federici S, Bruno L, Verde N, Lami A, Crespi CM, Marinelli, L, Giordani L, Matarrese P, Ruocco A, Santangelo C, Contoli B, Masonacco M, MInardi V, Chiarotti F, Fisher AD; Pierdominici M, JEI 2024
• 107) Gender affirming clinical care pathway for adolescents. Ristori J and Fisher AD. J Sex Med 2023 Oct 31;20(11):1266-1267.
• 106) Facilitators and barriers in HIV testing and continuum of care among migrant transgender women who are sex workers residing in Florence, Italy. Lagi et al. Int J Transgend Health 202318;25:268-282
• 105) Gender affirming hormone therapy and autoimmunity: new insights from a three year follow-up study. Marconi M, Riitano G, Fisher AD et al- Clin Exp Immunol 2023 Nov 14Exploring gender diversity in Transgender and Non-binary adults accessing specialized service in Italy. Mirabella et al Healthcare. 2023 Jul 28;11(15):2150
• 104) Exploring gender diversity in Transgender and Non-binary adults accessing specialized service in Italy. Mirabella et al Healthcare. 2023 Jul 28;11(15):2150
• 103) A comment from SIGIS, SIE and SIAMS: Puberty blockers in transgender adolescents - a matter of growing evidence and not of ideology. Ristori J, Motta G, Meriggiola MC, Bettocchi C, Crespi C, Falcone M, Lombardo F, Maggi M, Morelli G, Colao AM, Isidori AM, Fisher AD. J Endocrinol Invest. 2023 Sep 11.
• 102) Sex hormones, insomnia, and sleep quality: Subjective sleep in the first year of hormone use in transgender persons . Morssinkhof et al. Sleep Medicine 2023
• 101) Effects of hormonal treatment on dermatological outcome in transgender people: a multicentric prospective study (ENIGI). J End Inv 2023
• 100) Standards of Care for the Health of Transgender and Gender Diverse People, Version 8. World Professional Association for Transgender Health. Coleman et al. Int J Transgend Health 2022; 15;10(4):100522
• 99) A Novel Compound Heterozygous Mutation of HSD17B3 Gene Identified in a Patient With 46,XY Difference of Sexual Development. J End Invest 2022
• 98) Hypersexuality as a tip of the iceberg of a primary psychopathology: a joined position statement of the Italian Society of Andrology and SSexual Medicine (SIAMS) and of the Italian Society of Psychopathology (SOPSI). Limoncin et al., JEI 2022; 45: 1787-1799
• 97) The ENIGI (European Network for the Investigation of Gender Incongruence) study: overview of acquired endocrine knowledge and future perspectives. J Clin Med 2022 Mar 24;11(7):1784
• 96) SIGIS-SIAMS-SIE position statement of gender affirming hormonal treatment in transgender and non-binary people. Fisher AD et al, J Endocr Invest 2022; 45:657-673
• 95) The fMRI correlates of visuo-spatial abilities: sex differences and gender dysphoria. Gavazzi G and Fisher AD et al, Brain Imaging Behav 2022: 16:955-64
• 94) ESSM Position Statement "Sexual Wellbeing After Gender Affirming Surgery. J Sex Med 2022; 31; 00824-4
• 93) Prevalence and Correlates of Sexually Transmitted Infections in Transgender People: An Italian Multicentric Cross-Sectional Study.J Clin Med. 2022 May 14;11(10):2774
• 92) Apparent autistic traits in transgender people: a prospective study of the impact of gender-affirming hormonal treatment. J End Invest 2022; 45:2059-68
• 91) Management of hypoactive sexual desire disorder in transgender women: a guide for clinicians. Int J Impot Res 2020;33:703-709
• 90) Psychological Wellbeing and Perceived Social Acceptance in Gender Diverse Individuals.Romani A, Mazzoli F, Ristori J, Cocchetti C, Cassioli E, Castellini G, Mosconi M, Meriggiola MC, Gualdi S, Giovanardi G, Lingiardi V, Vignozzi L, Maggi M, Fisher AD.J Sex Med. 2021;18(11):1933-1944.
• 89) Positive and Negative Affect Changes during Gender-Affirming Hormonal Treatment: Results from the European Network for the Investigation of Gender Incongruence (ENIGI).J Clin Med. 2021 Jan 14;10(2):296.
• 79) Mental Health and Endocrine Telemedicine Consultations in Transgender Subjects During the COVID-19 Outbreak in Italy: A Cross-Sectional Web-Based Survey.J Sex Med. 2021 May;18(5):900-907.
• 78) Toward a Lowest Effective Dose of Cyproterone Acetate in Trans Women: Results From the ENIGI Study.J Clin Endocrinol Metab. 2021 Sep 27;106(10):e3936-e3945
• 77) The Neuroanatomy of Transgender Identity: Mega-Analytic Findings From the ENIGMA Transgender Persons Working Group. J Sex Med. 2021;18(6):1122-1129
• 76) Sexual habits among Italian transgender adolescents: a cross-sectional study. Ristori J, Rossi E, Cocchetti C, Mazzoli F, Castellini G; Ricca V, Maggi M, Fisher AD. Int J Impot Res 2020 Nov;33(7):687-693
• 75) Sexual orientation in transgender individuals: results from the longitudinal ENIGI study. Int J Impot Res 2020 Nov;33(7):694-702
• 74) Is there a need for liver enzyme monitoring in people using gender-affirming hormone therapy?Eur J Endocrinol 2021
• 73) Management of premature ejaculation: a clinical guideline from the Italian Society of Andrology and Sexual Medicine (SIAMS).J Endocrinol Invest. 2021
• 115) Stratified analysis of health and gender-affirming care among Italian transgender and gender diverse adults. Marconi et al. J Endocrinol Invest. 2025 Feb 15. doi: 10.1007/s40618-025-02547-y
• 114) The attitudes of transgender and gender-diverse adolescents and their parents regarding fertility, parenthood, and fertility preservation before the start of puberty suppression or gender-affirming hormone therapy. Stolk J Sex Med. 2025 Mar 7:qdaf029. doi: 10.1093/jsxmed/qdaf029
• 113) Predictors of Stigma Towards Transgender and Gender Non-Conforming Individuals Among Registered Dietitians and Dietetics Students. Stigma and Health. - ISSN 2376-6964. 2025
• 72) Vaginal bleeding and spotting in transgender men after initiation of testosterone therapy: A prospective cohort study (ENIGI) Defreyne J et al. Int J Transgend Health. 2020 Feb 12;21(2):163-175. doi: 10.1080/26895269.2020.1719951
• 71) Predictors of resumption of menses in Anorexia Nervosa: A four-year longitudinal study. Castellini G,Rossi E, Cassioli E, Giardinelli L, Fanelli A, Fisher AD, Vignozzi L, Ricca V. Psychosom Med 2020 Oct;82(8):782-786. doi: 10.1097/PSY.0000000000000849.
• 70) Neural Correlates of Gender Face Perception in Transgender People. Fisher AD, Ristori J, Castellini G, Cocchetti C, Cassioli E, Orsolini S, Sensi C, Romani A, Mazzoli F, Cipriani A, Ricca V, Vignozzi L, Viggiano MP, Mascalchi M, Maggi M, Gavazzi G. J Clin Med IF 3. 2020 Jun 3;9(6):1731. doi: 10.3390/jcm9061731
• 69) Hormonal Treatment Strategies Tailored to Non-Binary Transgender Individuals. Cocchetti C, Ristori J, Romani A, Maggi M, Fisher AD. J Clin Med. 2020 May 26;9(6):1609. doi: 10.3390/jcm9061609.
• 68) Brain Sex Differences Related to Gender Identity Development: Genes or Hormones? Ristori J, Cocchetti C, Romani A, Mazzoli F, Vignozzi L, Maggi M, Fisher AD. Int J Mol Sci. 2020 Mar 19;21(6):2123. doi: 10.3390/ijms21062123. IF 5.6
• 67) When Testosterone Needs to be Contrasted: A Preliminary Study of Scar Prevention in Transmen Top Surgery with an Innovative Galenic Preparation. Tanini S, Calabrese S, Fisher AD, Maggi M, Lo Russo G. Aesthetic Plast Surg. 2020 Jun;44(3):1006-1013. doi: 10.1007/s00266-020-01678-2. IF 1.3
• 66) European Society for Sexual Medicine Position Statement "Assessment and Hormonal Management in Adolescent and Adult Trans People, With Attention for Sexual Function and Satisfaction". T'Sjoen G, Arcelus J, De Vries ALC, Fisher AD, Nieder TO, Özer M, Motmans J. J Sex Med. 2020 Apr;17(4):570-584. doi: 10.1016/j.jsxm.2020.01.012. IF 3.3
• 65) Lower Serum Estradiol Levels in Assigned Female at Birth Transgender People with Initiation of Testosterone Therapy: Results from the European Network for the Investigation of Gender Incongruence.Defreyne J, Aers XP, Collet SM, Wiepjes CM, Fisher AD, Schreiner T, Den Heijer M, Kaufman JM, T'Sjoen GGR. LGBT Health. 2020 Feb/Mar;7(2):71-81. doi: 10.1089/lgbt.2019.0260. IF 3.9
• 64) 5α-Reductase-2 deficiency: is gender assignment recommended in infancy? Two case-reports and review of the literature.Cocchetti C, Ristori J, Mazzoli F, Prunas A, Bertelloni S, Magini A, Vignozzi L, Maggi M, Fisher AD. J Endocrinol Invest. 2020 Aug;43(8):1131-1136. doi: 10.1007/s40618-020-01193-w IF 3.9
• 63) Sexual Desire Changes in Transgender Individuals Upon Initiation of Hormone Treatment: Results From the Longitudinal European Network for the Investigation of Gender Incongruence.Defreyne J, Elaut E, Kreukels B, Fisher AD, Castellini G, Staphorsius A, Den Heijer M, Heylens G, T'Sjoen G. J Sex Med. 2020 Apr;17(4):812-825. doi: 10.1016/j.jsxm.2019.12.020. Epub 2020 Jan 31. IF 3.3
• 62) Hormonal Treatment Effect on Sexual Distress in Transgender Persons: 2-Year Follow-Up Data. Ristori J, Cocchetti C, Castellini G, Pierdominici M, Cipriani A, Testi D, Gavazzi G, Mazzoli F, Mosconi M, Meriggiola MC, Cassioli E, Vignozzi L, Ricca V, Maggi M, Fisher AD. J Sex Med. 2020 Jan;17(1):142-151. doi: 10.1016/j.jsxm.2019.10.008 IF 3.3
• 61) Explorative Prospective Evaluation of Short-Term Subjective Effects of Hormonal Treatment in Trans People-Results from the European Network for the Investigation of Gender Incongruence. van Dijk D, Dekker MJHJ, Conemans EB, Wiepjes CM, de Goeij EGM, Overbeek KA, Fisher AD, den Heijer M, T'Sjoen G. J Sex Med. 2019 Aug;16(8):1297-1309. DOI: 10.1016/j.jsxm.2019.05.009 IF 3.3
• 60) Gender Dysphoria and Anorexia Nervosa Symptoms in Two Adolescents. Ristori J, Fisher AD, Castellini G, Sensi C, Cipriani A, Ricca V, Maggi M. Arch Sex Behav. 2019 Jul;48(5):1625-1631.DOI: 10.1007/s10508-019-1396-7 IF 2.9
• 59) Neuropsychiatric Aspects in Men with Klinefelter Syndrome Giagulli VA, Capone B, Castellana M, Salzano C, Fisher AD, de Angelis C, Pivonello R, Colao A, Pasquali D, Maggi M, Triggiani V; Klinefelter ItaliaN Group (KING). Endocr Metab Immune Disord Drug Target 2019;19(2):109-115. doi: 10.2174/1871530318666180703160250. IF 2
• 58) Breast Development in Transwomen After One Year of Cross-sex Hormone Therapy: Results of A Prospective Multicenter Study. de Blok CJM, Klaver M, Wiepjes C, Nota N, Heijboer A, Fisher AD, Schreiner T, T’Sjoen G, Den Heijer M.J Clin Endocrinol Metab. 2018 Feb 1;103(2):532-53. IF 4.25 DOI: 10.1210/jc.2017-01927
• 57) Deviance or Normalcy? The Relationship Among Paraphilic Thoughts and Behaviors, Hypersexuality, and Psychopathology in a Sample of University Students.Castellini G, Rellini AH, Appignanesi C, Pinucci I, Fattorini M, Grano E, Fisher AD, Cassioli E, Lelli L, Maggi M, Ricca V. J Sex Med. 2018 Sep;15(9):1322-1335 DOI: 10.1016/j.jsxm.2018.07.015 IF 3.3
• 56) Changes in regional body fat, lean body mass and body shape in trans persons using cross-sex hormonal therapy: results from a multicenter prospective study. Klaver M, de Blok CJM, Wiepjes CM, Nota NM, Dekker MJHJ, de Mutsert R, Schreiner T, Fisher AD, T'Sjoen G, den Heijer M. Eur J Endocrinol. 2018 Feb;178(2):165-173 DOI: 10.1530/EJE-17-0496 IF 5.3
• 55) The molecular mechanisms of sexual orientation and gender identity. Fisher AD, Ristori J, Morelli G, Maggi M. Mol Cell Endocrinol. 2018 15;467:3-13 doi.org/10.1016/j.mce.2017.08.008 IF 1.13
• 54) Transient elevated serum prolactin in trans women is caused by cyproterone acetate treatment Defreyne J, Nota N, Perreira C, Schreiner T, Fisher AD, Den Heijer M, T’Sjoen G. LGBT Health. 2017 Sep 7. doi: 10.1089/lgbt.2016.0190 IF 3.9
• 56) Role of sexuality in the outcome of anorexia nervosa and bulimia nervosa: a three follow-up study. Castellini G, Lelli L, Corsi E, Campone B, Ciampi E, Fisher AD, Mallardo L, Monteleone AL, Rotella F, Tofani F, Vignozzi L, Zamponi F, Maggi M, Ricca V. Psychother Psychosom 2017;86:376–378 DOI: 10.1159/000477176 IF 16.3
• 53) Psychological characteristics of Italian Gender Dysphoric adolescents: a case control study. Fisher AD, Ristori J, Castellini G, Sensi C, Cassioli E, Prunas A, Mosconi M, Dèttore D, Ricca V, Maggi M.J Endocrinol Invest 2017 Sep;40(9):953-965. doi: 10.1007/s40618-017-0647-5. IF 3.9
• 52) Bone mineral density increases in trans persons after one year hormonal treatment: a multicenter prospective observational study. Wiepjes CM, Vlot MC, Klaver M, Nota MN, de Blok CJM, de Jongh RT, Lips P, Heijboer AC, Fisher AD, Schreiner T, T’Sjoen T, den Heijer M.Journal of Bone and Mineral Research 2017 Mar 29. doi: 10.1002/jbmr.3102. IF 5.1
• 51) Who has the worst attitudes toward sexual minorities? Comparison of transphobia and homophobia levels in gender dysphoric individuals, the general population and health care providers.Fisher AD, Castellini G, Ristori J, Casale H, Giovanardi G, Carone N, Fanni E, Mosconi M, Ciocca G, Jannini EA, Ricca V, Lingiardi V, Maggi M. J Endocrinol Invest. 2017;40(3):263-273 -3 IF 3.9 DOI: 10.1007/s40618-016-0552-3 IF 3.9
• 50) Cross-cultural and socio-demographic correlates of homophobic attitude among university students in three European countries.Ciocca G, Niolu C, Déttore D, Antonelli P, Conte S, Tuziak B, Limoncin E, Mollaioli D, Carosa E, Gravina G, Di Sante S, Di Lorenzo G, Fisher AD, Maggi M, Lenzi A, Siracusano A, Jannini EA. J Endocrinol Invest. 2017;40(2):227-233 IF 3.9 DOI: 10.1007/s40618-016-0554-1 IF 3.9
• 49) Cross-sex hormone treatment and psychobiological changes in transsexual persons: 2-yr follow-up data.Fisher AD, Castellini G, Ristori J, Casale E, Cassioli E, Sensi C, Fanni E, Amato ML, Bettini E, Dèttore D, Ricca V, Maggi M. J Clin Endocrinol Metab. 2016;101(11):4260-4269. DOI: 10.1210/jc.2016-1276 IF 4.25 PAPER VINCITORE DEL PREMIO “BEST JCEM 2016”
• 48) The role of somatic symptoms in sexual medicine: somatization as important contextual factor in male sexual dysfunction. Fanni E, Castellini G, Corona G, Boddi V, Ricca V, Rastrelli G, Fisher AD, Cipriani S, Maggi M. J Sex Med. 2016;13(9):1395-407. IF 3.3 DOI: 10.1016/j.jsxm.2016.07.002 IF 3.3
• 47) Gender identity, gender assignment and reassignment in individuals with disorders of sex development: a major dilemma. Review. Fisher AD, Ristori J, Fanni E, Castellini G, Forti G, Maggi M. J Endocrinol Invest. 2016;39(11):1207-1224 DOI: 10.1007/s40618-016-0482-0 IF 3.9
• 45) A European Network for the Investigation of Gender Incongruence: Endocrine Part.Dekker MJ, Wierckx K, Van Caenegem E, Klaver M, Kreukels BP, Elaut E, Fisher AD, van Trotsenburg MA, Schreiner T, den Heijer M, T'Sjoen G. J Sex Med. 2016;13(6):994-9. DOI: 10.1016/j.jsxm.2016.03.371 IF 3.3
• 45) Definitions of Sexual Dysfunctions in Women and Men: A Consensus Statement from the Fourth International Consultation on Sexual Medicine 2015. McCabe M, Sharlip IR, Atalla E, Balon R, Fisher AD, Laumann E, Lee SE, Lewis R, Segraves R. J Sex Med. 2016 ;13(2):135-43. DOI: 10.1016/j.jsxm.2015.12.019 IF 3.3
• 44) Incidence and Prevalence of Sexual Dysfunction in Women and Men:A Consensus Statement from the Fourth International Consultation on Sexual Medicine 2015 McCabe M, Sharlip IR, Atalla E, Balon R, Fisher AD, Laumann E, Lee SE, Lewis R, Segraves R. J Sex Med. 2016;13(2):144-52. DOI: 10.1016/j.jsxm.2015.12.034 IF 3.3
• 43) Risk Factors for Sexual Dysfunction among Women and Men: A Consensus Statement from the Fourth International Consultation on Sexual Medicine 2015. McCabe M, Sharlip IR, Atalla E, Balon R, Fisher AD, Laumann E, Lee SE, Lewis R, Segraves R.J Sex Med. 2016;13(2):153-67. IF 3.3 DOI: 10.1016/j.jsxm.2015.12.015 IF 3.
• 42) Experiences of violence, harassment and discrimination in a sample of Italian transsexuals who underwent sex reassignment surgery. Prunas A, Bandini E, Fisher AD, Maggi M, Pace V, Quagliarella L, Todarello O, Bini M. J Interpers Violence. 2018;33(14):2225-2240 DOI: 10.1177/0886260515624233 IF 2.6
• 41) Conflicts Within the Family and Within the Couple as Contextual Factors in the Determinism of Male Sexual Dysfunction. Boddi V, Fanni E, Castellini G, Fisher AD, Corona G, Maggi M. J Sex Med. 2015c;12:2425-35 DOI: 10.1111/jsm.13042 IF 3.3
• 40) Hypersexuality, Paraphilic Behaviors, and Gender Dysphoria in Individuals with Klinefelter's Syndrome. Fisher AD, Castellini G, Casale H, Fanni E, Bandini E, Campone B, Ferruccio N, Maseroli E, Boddi V, Dèttore D, Pizzocaro A, Balercia G, Oppo A, Ricca V, Maggi M. J Sex Med. 2015;12(12):2425-35 DOI: 10.1111/jsm.13048 IF 3.3
• 39 Psychoticism, Immature Defense Mechanisms and a Fearful Attachment Style are Associated with a Higher Homophobic Attitude. Ciocca G, Tuziak B, Limoncin E, Mollaioli D, Capuano N, Martini A, Carosa E, Fisher AD, Maggi M, Niolu C, Siracusano A, Lenzi A, Jannini EA. J Sex Med. 2015;12(9):1953-60 DOI: 10.1111/jsm.12975 IF 3.3
• 38) Gender dysphoria in adolescents: the need for a shared assessment protocol and the proposal of the AGIR protocol. Dèttore D, Ristori J, Antonelli P, Bandini E, Fisher AD, Villani S, de Vries A, Steensma T, Cohen-Kettenis P. Journal of Psychopathology 2015, 21:152-158.
• 37) Gender identity, but not sexual orientation, impacts on facial preferences. Ciocca G, Limoncin E, Cellerino A, Fisher AD, Gravina GL, Carosa El, Mollaioli D, Valenzano DR, Mennucci A, Bandini E, Lenzi A, Jannini EA J Sex Med. 2014;11(10):2500-7 doi.org/10.1111/jsm.12633 IF 3.3
• 36) Yes and yes again: are standards of care which require two referrals for genital reconstructive surgery ethical? Bouman WP, Richards C, Addinall RM, Arango de Montis I, Duisin D, Esteva I, Fisher AD, Harte F, Khoury B, Lu Z, Marais A, Nayarana Reddy D, Nieder TO, Robles Garcia R, Rodrigues jr OM, Roque Guerra A, Tereshkevich D, T’Sjoen G, Wilson D. Sexual and Relationship Therapy 2014; 29(4):377-389 DOI:10.1080/14681994.2014.954993 IF 1.5
• 35) Cross-sex hormone therapy in trans persons is safe and effective at short-time follow-up: results from the European Network for the Investigation of Gender Incongruence. Wierckx K, Van Caenegem E, Schreiner T, Haraldsen I, Fisher AD, Toye K, Kaufman JM, T’Sjoen G.J Sex Med. 2014;11(8):1999-2011 IF 3.3 DOI: 10.1111/jsm.12571 IF 3.3
• 34) Medical treatment in gender dysphoric adolescents endorsed by SIAMS–SIE–SIEDP–ONIG. Fisher AD, Ristori J, Bandini E, Giordano S, Mosconi M, Jannini EA, Greggio NA, Godano A, Manieri C, Ricca V, ONIG GnRH Study Group, Dèttore D, Maggi M.J Endocrinol Invest. 2014;37(7):675-87 DOI: 10.1007/s40618-014-0077-6 IF 3.9
• 33) Lack of Sexual Privacy Affects Psychological and Marital Domains of Male Sexual DysfunctionBoddi V, Fisher AD, Maseroli E, Rastrelli G, Corona G, Jannini E, Ricca V, Mannucci E, Maggi MJ Sex Med 2014 Feb;11:431-8. doi: 10.1111/jsm.12382. IF 3.3
• 32) Cross-Sex Hormonal Treatment and Body Uneasiness in Individuals with Gender Dysphoria.Fisher AD, Castellini G, Bandini E, Casale H, Fanni E, Benni L, Ferruccio N, Meriggiola MC, Manieri C, Gualerzi A, Jannini E, Oppo A, Ricca V, Maggi M, Rellini AH. J Sex Med. 2014;11(3):709-19 DOI: 10.1111/jsm.12413 IF 3.3
• 31) Sociodemographic and Clinical features of gender identity disorder: an Italian multicentric evaluation. Fisher AD, Bandini E, Casale H, Ferruccio, N, Meriggiola M, Gualerzi A, Manieri C, Jannini EA, Mannucci E, Monami M, Stomaci N, Delle Rose A, Susini T, Ricca V, Maggi M. J Sex Med 2013;10:408-19. doi.org/10.1111/j.1743-6109.2012.03006.x IF 3.3
• 30) Gender Identity Disorder and Eating Disorder: similarities and differences in terms of body uneasiness. Bandini E and Fisher AD, Castellini G, Lo Sauro C, Lelli L, Meriggiola MC, Benni L, Casale H, Ferruccio N, Faravelli, Dèttore D, Maggi M, Ricca V. J Sex Med 2013;10:1012-23 DOI: 10.1111/jsm.12062 IF 3.3
• 29) “It takes two to tango”: the relational domain in a cohort of subjects with erectile dysfunction. Boddi V, Corona G, Fisher AD, Mannucci E, Ricca V, Sforza A, Forti G, Maggi M. J Sex Med 2012;9:3126-36 IF 3.3 doi.org/10.1111/j.1743-6109.2012.02948.x
• 28) Two unconventional risk factors for major adverse cardiovascular events in subjects with sexual dysfunction: low education and reported partner’s hypoactive sexual desire in comparison with conventional risk factors. Rastrelli R, Corona G, Fisher AD, Silverii A, Mannucci E, Maggi M. J Sex Med. 2012;9(12):3227-38 IF 3.3 doi.org/10.1111/j.1743-6109.2012.02947.x
• 27) Metabolic and Cardiovascular Outcomes of Fatherhood: results from a cohort study in subjects with sexual dysfunction.Fisher AD, Rastrelli G, Bandini E, Corona G, Balzi D, Melani C, Monami M, Matta V, Mannucci E, Maggi M. J Sex Med 2012;9:2785-94 DOI: 10.1111/j.1743-6109.2012.02865.x IF 3.3.
• 26) Sexual and cardiovascular correlates of male unfaithfulness. Review article. Fisher AD, Bandini E, Rastrelli G, Corona G, Monami M, Mannucci E, Maggi M. Review article. J Sex Med 2012;9:1508-18 doi.org/10.1111/j.1743-6109.2012.02722.x IF 3.3.
• 25) Stable extramarital affairs are breaking the hearth. Fisher AD, Bandini E, Corona G, Monami M, Cameron Smith Michela, Melani C, Balzi D, Forti G, Mannucci M, Maggi M. Int J Andr 2012;35:11-17 doi.org/10.1111/j.1365-2605.2011.01176.x
• 24) Childhood maltreatment in subjects with Male to Female Gender Identity Disorder. Bandini E, Fisher AD, Ricca V, Ristori J, Meriggiola MC, Jannini EA, Manieri C, Corona G, Monami M, Forti G, Mannucci E, Maggi M. Int J Andr 2011;23:276-85 DOI: 10.1038/ijir.2011.39
• 23) Severe depressive symptoms and cardiovascular risk in subjects with erectile dysfunction. Bandini E, Fisher AD, Corona G, Ricca V, Monami M, Boddi V, Balzi D, Melani C, Forti G, Mannucci E, Maggi M. J Sex Med 2010;7(10):3477-86. DOI: 10.1111/j.1743-6109.2010.01936.x IF 3.3
• 22) Priapus is happier with Venus than with Dionysus. Boddi V, Corona G, Monami M, Fisher AD, Bandini E, Melani C., Balzi D, Sforza A., Patussi V., Forti G, Mannucci E, Maggi M. J Sex Med 2010 7(8):2831-41. IF 3.3 doi.org/10.1111/j.1743-6109.2010.02112_9.x
• 21) Psychobiological correlates of women’s sexual interest as perceived by patients with erectile dysfunction. Corona G, Bandini E, Fisher AD, Maseroli E, Boddi V, Sforza A, Balercia G, Forti G, Mannucci E, Maggi M. J Sex Med. 2010, 7:2174-83 DOI: 10.1111/j.1743-6109.2010.01812.x IF 3.3
• 20) Low Testosterone is Associated with an Increased Risk of MACE Lethality in Subjects with Erectile Dysfunction. Corona G, Monami M, Boddi V, Cameron-Smith M, Fisher AD, de Vita G, Melani C, Balzi D, Sforza A, Forti G, Mannucci E, Maggi M. J Sex Med 2010;7:1557-6493 IF 3.3 DOI: 10.1111/j.1743-6109.2009.01690.x
• 19) Dimensional profiles of Male to Female Gender Identity Disorder: an exploratory research. Fisher AD, Bandini E, Ricca V, Ferruccio N, Corona G, Meriggiola MC, Jannini EA, Manieri C, Ristori J, Forti G, Mannucci E, Maggi M. J Sex Med 2010;7:2487-98 doi.org/10.1111/j.1743-6109.2009.01687.x IF 3.3
• 18) Autoeroticism, Mental Health, and Organic Disturbances in Patients with Erectile Dysfunction. Corona G, Ricca V, Boddi V, Bandini E, Lotti F, Fisher AD, Sforza A, Forti G, Mannucci E, Maggi M. J Sex Med. 2010;7:182-91. DOI: 10.1111/j.1743-6109.2009.01497.x IF 3.3
• 17) Sexual dysfunction in subjects with Klinefelter's syndrome. Corona G, Petrone L, Paggi F, Lotti F, Boddi V, Fisher AD, Vignozzi L, Balercia G, Sforza A, Forti G, Mannucci E, Maggi M. Int J Androl. 2009;32:1-8 IF. DOI: 10.1111/j.1365-2605.2009.00986.x
• 16) Impairment of couple relationship in male patients with sexual dysfunction is associated with overt hypogonadism. Corona G, Mannucci E, Lotti F, Boddi V, Jannini EA, Fisher AD, Monami M, Sforza A, Forti G, Maggi M. J Sex Med. 2009;6:2591-2600 IF 3.3 DOI: 10.1111/j.1743-6109.2009.01352.x
• 15) Hysterical traits are not from the uterus but from the testis: a study in men with sexual dysfunction. Bandini E, Corona G, Ricca V, Fisher AD, Lotti F, Sforza A, Faravelli C, Forti G, Mannucci E, Maggi M. J Sex Med. 2009;6:2321-2331.DOI: 10.1111/j.1743-6109.2009.01322.x IF 3.3
• 14) Cardiovascular risk engines can help in selecting patients to be evaluated by dynamic penile color Doppler ultrasound. Corona G, Mannucci E, Fisher AD, Lotti F, Bandini E, Vignozzi L, Balercia G, Paggi F, Petrone L, Forti G, Maggi M. J Endocrinol Invest. 2008;31:1058- 1062;31. DOI: 10.1007/BF03345652 IF 3.9
• 13) Pulse pressure, an index of arterial stiffness, is associated with androgen deficiency and impaired penile blood flow in men with ED. Corona G, Mannucci E, Lotti F, Fisher AD, Bandini E, Balercia G, Forti G, Maggi M. J Sex Med. 2009;6:285-93. IF 3.3 DOI: 10.1111/j.1743-6109.2008.01059.x IF 3.3
• 12) Psychobiological Correlates of Extramarital Affairs and Differences between Stable and Occasional Infidelity among Men with Sexual Dysfunctions. Fisher AD, Corona G, Bandini E, Mannucci E, Lotti F, Boddi V, Forti G, Maggi M. J Sex Med. 2009;6:866-875. DOI: 10.1111/j.1743-6109.2008.01140.x IF 3.3
• 11) Six-month administration of 1% testosterone gel is able to restore erectile function in hypogonadal patients with erectile dysfunction. Corona G, Petrone L, Fisher AD, Mansani R, Bandini E, Boddi V, Lotti F, Forti G, Maggi M. Arch Ital Urol Androl. 2008;80:103-108. PMID: 19009866
• 10) Low levels of androgens in men with erectile dysfunction and obesity. Corona G, Mannucci E, Fisher AD, Lotti F, Petrone L, Balercia G, Bandini E, Forti G, Maggi M. J Sex Med. 2008;5:2454-2463 IF 3.3 DOI: 10.1111/j.1743-6109.2008.00856.x
• 9) Different Testosterone Levels Are Associated with ejaculatory Dysfunction. Corona G, Jannini EA, Mannucci E, Fisher AD, Lotti F, Petrone L, Balercia G, Bandini E, Chiarini V, Forti G, Maggi M. J Sex Med. 2008;5:1991-1998. IF 3.3 : 10.1111/j.1743-6109.2008.00803.x IF 3.3
• 8) Association between psychiatric symptoms and erectile dysfunction. Corona G, Ricca V, Bandini E, Mannucci E, Petrone L, Fisher AD, Lotti F, Balercia G, Faravelli C, Forti G, Maggi M. J Sex Med. 2008;5:458-468 IF 3.3 DOI: 10.1111/j.1743-6109.2007.00663.x IF 3.3
• 7) Toward the Establishment of a European Qualification in Sexual Medicine: The ESSM Specialist Training Course, Oxford 2007. Report. International Society for Sexual Medicine. John Dean MBBS, J Sex Med 2007;4:1553-1558 doi.org/10.1111/j.1743-6109.2007.00618.x
• 6) Effect of hyperprolactinemia in male patients consulting for sexual dysfunction. Corona G, Mannucci E, Fisher AD, Lotti F, Ricca V, Balercia G, Petrone L, Forti G, Maggi M. J Sex Med. 2007;4:1485-1493. DOI: 10.1111/j.1743-6109.2007.00569.x IF 3.3
• 5) NCEP-ATPIII-defined metabolic syndrome, type 2 diabetes mellitus, and prevalence of hypogonadism in male patients with sexual dysfunction. Corona G, Mannucci E, Petrone L, Balercia G, Paggi F, Fisher AD, Lotti F, Chiarini V, Fedele D, Forti G, Maggi M. J Sex Med. 2007;4:1038-45. IF 3,3 DOI: 10.1111/j.1743-6109.2007.00569.x IF 3.3
• 4) Comparison of NCEP-ATPIII and IDF Metabolic Syndrome Definitions with Relation to Metabolic Syndrome-Associated Sexual Dysfunction. Corona G, Mannucci E, Petrone L, Schulman C, Balercia G, Fisher AD, Chiarini V, Forti G, Maggi M.J Sex Med. 2007;4:789-96 IF 3.3 DOI: 10.1111/j.1743-6109.2007.00498.x IF 3.3
• 3) ANDROTEST: a structured interview for the screening of hypogonadism in patients with sexual dysfunction. Corona G, Mannucci E, Petrone L, Balercia G, Fisher AD, Chiarini V, Forti G, Maggi M. J Sex Med. 2006;3:706-15 IF 3.3 DOI: 10.1111/j.1743-6109.2006.00262.x IF 3.3
• 2) Psychobiological correlates of delayed ejaculation in male patients with sexual dysfunctions. Corona G, Mannucci E, Petrone L, Fisher AD, Balercia G, De Scisciolo G, Pizzocaro A, Giommi R, Chiarini V, Forti G, Maggi M. J Androl. 2006:27:453-458. DOI: 10.2164/jandrol.05154
• 1) Identification, characterization and biological activity of oxytocin receptor in the developing human penis. Vignozzi L, Vannelli GB, Morelli A, Mancina R, Marini M, Ferruzzi P, Crescioli C, Luconi M, Donati S, Fisher AD, Baldi E, Filippi S, Forti G, Maggi M. Mol Hum Reprod. 2005;11:99-106. IF 3.6 DOI: 10.1093/molehr/gah138

Patologie trattate

• Tiroidite di hashimoto
• Obesità
• Tumore della tiroide
• Malattia di basedowgraves
• Ipercolesterolemia
• Ipogonadismo
• Malattia di addison
• Menopausa
• Impotenza
• Infertilità
• Irsutismo
• Disfunzione erettile
• Presa in carico ormonale in incongruenza di genere
• Ipotiroidismo
• Ipertiroidismo
• Noduli tiroidei
• Endocrinologia ginecologica

Profili social